CYP3A5 pharmacogenetic testing for tacrolimus in pediatric heart transplant patients: a budget impact analysis [0.03%]
他克莫司儿科心脏移植患者CYP3A5药物基因组检测的预算影响分析
Jiaqi Wang,Amy L Pasternak,Simran Maggo et al.
Jiaqi Wang et al.
Background: Pharmacogenomic testing can optimize drug efficacy and minimize adverse effects. CYP3A5 polymorphisms affect the metabolism of tacrolimus. We sought to estimate the budget impact of preemptive pharmacogenomic ...
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort [0.03%]
巴西一大型队列中的药物基因组学与结核病治疗毒副反应及疗效的关系研究
Gustavo Amorim,James Jaworski,Jing Yang et al.
Gustavo Amorim et al.
Background: Genetic polymorphisms have been associated with risk of antituberculosis treatment toxicity. We characterized associations with adverse events and treatment failure/recurrence among adults treated for tubercul...
Observational Study
Pharmacogenetics and genomics. 2025 Feb 1;35(2):55-64. DOI:10.1097/FPC.0000000000000552 2025
Budget impact analysis of TPMT and NUDT15 pharmacogenomic testing for 6-mercaptopurine in pediatric acute lymphoblastic leukemia patients [0.03%]
儿童急性淋巴细胞白血病患者进行硫嘌呤甲基转移酶和尿苷二磷酸葡萄糖醛酸基转移酶15基因检测的预算影响分析
Beverly Fuerte,Mia Burgos,Vyvy Cao et al.
Beverly Fuerte et al.
Background: Pharmacogenomic testing identifies gene polymorphisms impacting drug metabolism, aiding in optimizing treatment efficacy and minimizing toxicity, thus potentially reducing healthcare utilization. 6-Mercaptopur...
Philadelphia chromosome-positive or Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with multilineage involvement in pediatric patients: a report of two cases and literature review [0.03%]
儿童多系受侵的Ph染色体阳性或Ph样B细胞急性淋巴细胞白血病2例报道及文献复习
Han Lin,Lu Chen,Ruoyao Huang et al.
Han Lin et al.
Based on driver mutations and gene expression profiles, the International Consensus Classification currently divided the entity 'Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukemia (ALL)' into two subtypes: ...
Comparative performance of pharmacogenetics-based warfarin dosing algorithms in Chinese population: use of a pharmacokinetic/pharmacodynamic model to explore dosing regimen through clinical trial simulation [0.03%]
基于药理基因组学的华法林剂量算法在中国人群中的比较效果:使用药代动力学/药效学模型通过临床试验模拟探索给药方案
Keli Shi,Jiexin Deng
Keli Shi
Objective: Warfarin has a narrow therapeutic window and large variability in dosing that are affected by clinical and genetic factors. To help guide the dosing of warfarin, the Clinical Pharmacogenetics Implementation Con...
Comparative Study
Pharmacogenetics and genomics. 2024 Dec 1;34(9):275-284. DOI:10.1097/FPC.0000000000000545 2024
Comparative performance of pharmacogenetics-based warfarin dosing algorithms in Chinese population: use of a pharmacokinetic/pharmacodynamic model to explore dosing regimen through clinical trial simulation [0.03%]
基于药理基因组学的华法林剂量计算方法在中国人群中的比较研究:运用药动/药效模型通过临床试验模拟探索给药方案
Keli Shi,Jiexin Deng
Keli Shi
Objective: Warfarin has a narrow therapeutic window and large variability in dosing that are affected by clinical and genetic factors. To help guide the dosing of warfarin, the Clinical Pharmacogenetics Implementation Con...
Comparative Study
Pharmacogenetics and genomics. 2024 Dec 1;34(9):275-284. DOI:10.1097/FPC.0000000000000545 2024
Influence of CYP2C9 phenotypes on phenytoin plasma concentration in neurosurgical Brazilian patients [0.03%]
CYP2C9表型对神经外科巴西患者苯妥英血药浓度的影响
Pedro Kurtz,Anna Beatriz Ribeiro Elias,Guilherme Suarez-Kurtz
Pedro Kurtz
Aims: To investigate the association of CYP2C9 metabolic phenotypes with phenytoin plasma concentration ([PTH]) in neurosurgical patients from the Brazilian Public Health System. ...
Differential distribution of NAT2 polymorphisms and NAT2 acetylator phenotypes among indigenous populations of the Brazilian Amazon [0.03%]
巴西亚马孙地区的土著人群中NAT2多态性和NAT2表型的分布差异
Jamila A Perini,Paulo C Basta,Jessica V Cardoso et al.
Jamila A Perini et al.
Objectives: We report, for the first time, the distribution of four no-function NAT2 single nucleotide polymorphisms and inferred NAT2 acetylator phenotypes in three indigenous groups (Munduruku, Paiter-Suruí, and Yanoma...
Impact of UGT1A4 and UGT2B7 polymorphisms on lamotrigine plasma concentration in patients with bipolar disorder [0.03%]
UGT1A4和UGT2B7多态性对双相情感障碍患者拉莫三嗪血药浓度的影响
Ting Zhao,Hui-Lan Zhang,Jie Feng et al.
Ting Zhao et al.
Purpose: The purpose of this study was to evaluate the effect of UGT1A4 and UGT2B7 polymorphisms on the plasma concentration of lamotrigine in Chinese patients with bipolar disorder. ...
The reduced function allele SLCO1B1 c.521T>C is of no practical relevance for the renal graft function over the first post-transplant year in patients treated with mycophenolic acid [0.03%]
SLCO1B1 c.521T>C(功能减少型等位基因)与接受霉酚酸治疗的肾移植患者移植后第一年内移植物功能无关
Sandra Nađ Škegro,Luka Penezić,Livija Šimičević et al.
Sandra Nađ Škegro et al.
Objective: It is unclear whether renal transplant recipients treated with mycophenolic acid (MPA) who carry the reduced-function allele at polymorphism SLCO1B1 c.521T>C differ from their wild-type peers regarding renal ou...
Observational Study
Pharmacogenetics and genomics. 2024 Sep 1;34(7):226-235. DOI:10.1097/FPC.0000000000000539 2024